药品名称DIAMOX
申请号008943产品号002
活性成分ACETAZOLAMIDE市场状态停止上市
剂型或给药途径TABLET;ORAL规格250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
008943048AP1999/01/05Package Change
008943047AP1991/02/14Control Supplement
008943046AP1990/11/28Labeling Revision
008943045AP1990/04/23Control Supplement
008943044AP1990/01/24Labeling Revision
008943043AP1989/12/06Labeling Revision
008943042AP1988/07/21Expiration Date Change
008943041AP1988/06/22Labeling Revision
008943040AP1987/08/11Labeling Revision
008943039AP1987/06/16Control Supplement
008943038AP1987/10/06Control Supplement
008943037AP1987/03/03Labeling Revision
008943036AP1986/03/21Labeling Revision
008943035AP1985/05/13Labeling Revision
008943034AP1984/09/25Control Supplement
008943033AP1984/02/22Formulation Revision
008943032AP1982/09/29Control Supplement
008943031AP1982/04/02Package Change
008943030AP1981/06/12Formulation Revision
008943029AP1980/12/17Formulation Revision
008943028AP1980/12/17Formulation Revision
008943027AP1980/12/17Control Supplement
008943026AP1979/08/30Formulation Revision
008943025AP1984/02/14Control Supplement
008943024AP1979/07/31Control Supplement
008943023AP1978/10/02Labeling Revision
008943022AP1978/04/07Control Supplement
008943021AP1978/04/03Formulation Revision
008943020AP1978/01/09Control Supplement
008943019AP1977/06/29Control Supplement
008943018AP1977/06/29Formulation Revision
008943017AP1977/06/06Expiration Date Change
008943015AP1977/01/28Expiration Date Change
008943013AP1977/01/28Formulation Revision
008943000AP1953/07/27Approval